Indications for permanent pacing The major indications for pacing for bradycardia are symptom relief and the improvement of prognosis. Symptoms of bradycardias include syncope (Adams-Stokes' attacks), lesser degrees of disturbed consciousness, breathlessness, fatigue, and chest pain. Depending on the underlying pathology, other symptoms may be secondary to associated abnormal tachycardias or emboli. The prognosis is influenced by the underlying pathology. The major pathologies are sinoatrial disease (31% of United Kingdom implants) and atrioventricular conduction abnormalities (54%) as well as carotid sinus hypersensitivity. These entities may occur alone or in combination. Pacing may also be indicated for the termination of reentrant tachycardias but this is an uncommon indication and is beyond the scope of this article.
Pacing modes
In 1958 the first permanent pacemaker was implanted into a human.' This was an epicardial, ventricular fixed rate device. Since then pacemaker complexity has increased until endocardial pacing and sensing of the right atrium, right ventricle, or both are possible with programmable devices that can vary the pacing rate according to the patient's needs.
Simple ventricular demand pacemakers commit the patient to a constant pacing rate and are unresponsive to fluctuating metabolic needs. Atrioventricular synchrony is lost and retrograde atrioventricular conduction may occur producing unpleasant symptoms and deleterious haemodynamic effects (pacemaker syndrome).4 Symptoms of the pacemaker syndrome include breathlessness, weakness, dizziness, presyncope, pulsations in the neck and palpitation. Heldman et al randomised 40 patients blindly to VVI or dual chamber pacing in a crossover study.5 Pacemaker syndrome was recognised in 83% of patients in the VVI mode and was moderate or severe in 65% (intolerable in 42%). Atrial pacing alone may be useful in some patients with sinoatrial disease.
To overcome problems associated with a constant pacing rate, more sophisticated pacemakers have been developed. One solution has been to control the pacing rate according to one of a multitude of physiological variables (rate responsive pacing). These include variables such as the QT interval,6 respiratory rate,7 minute ventilation,8 mixed venous temperature,9 or oxygen saturation,'0 which reflect metabolic needs. Other sensors simply respond to varying levels of activity by detecting motion in different ways." 12 All these systems have been shown to be clinically practical and useful, and implantation is usually identical to a standard single chamber system. There are problems with all of these systems, however; some of them may be specifically sensor related."'3-5 Furthermore, patients with ventricular demand systems (VVIR) will also lose atrioventricular synchrony and may be subject to the pacemaker syndrome. In addition, some sensors are not ideal for atrial rate-responsive demand pacing (AAIR) .
Another method of obtaining rate response is to sense the natural atrial rate. This requires a dual chamber system. Originally these systems could neither pace the atrium nor sense the ventricle (VAT mode). Then ventricular sensing was achieved (VDD mode), and now most dual chamber pacemakers are capable of operating in the "universal" DDD mode, which allows atrial synchronous ventricular pacing with additional demand atrial pacing and ventricular sensing. A more recent development has been the DDI mode which allows atrioventricular sequential pacing at a constant rate with both atrial and ventricular sensing but where ventricular pacing is not triggered by atrial sensing. The DVI mode, which has been superseded by DDI, was similar but without atrial sensing.
Conventional dual chamber pacemakers overcome many problems by providing rate response, maintaining atrioventricular synchrony, and preventing the pacemaker syndrome. Their value is limited when there is chronotropic incompetence or if there are persistent atrial arrhythmias. Problems specific to dual chamber pacemakers are related to implantation and to the increased complexity of the hardware. Two pacing leads are generally required, although single pass leads have occasionally been used. Refinements such as the development of thin bipolar leads with various fixation mechanisms have circumvented problems related to both implantation and atrial sensing so that most centres find little additional difficulty with dual chamber compared with single chamber implants. Joseph et al,"6 in a district general hospital, had a longterm success rate of 98% using modem atrial leads. Pacemaker mediated reentrant or "endless loop" tachycardia is a problem exclusive to dual chamber pacemakers.'7 It occurs in some patients with retrograde conduction (from ventricle to atrium) through sensing of retrograde atrial activation, and is often at the upper rate limit of the pacemaker. However, modem pacemaker design has minimised this problem.
To cope with patients with chronotropic incompetence, some dual chamber pacemakers are now available with a non-atrial sensor thus offering, for example, DDDR or DDIR pacing. These pacemakers also allow selection of the ventricular rate responsive mode if, for example, atrial fibrillation develops in a patient already being paced for atrioventricular block. Rosenqvist et al showed that in patients free from atrial fibrillation at the time of implant, 47% of those paced from the ventricle (VVI) developed persistent atrial fibrillation compared with 6-7% (p < 0-0005) paced with atrial inhibited pacemakers (AAI) over a four year follow up.'9 The VVI group had a higher incidence of congestive heart failure (37%) than the AAI group (15%, p < 0 005), and a higher mortality (23% compared with 8%, p < 0-05). Several other studies have also shown the value ofpacing the atrium in preventing atrial fibrillation.2"22 The risk of systemic embolism probably influences the prognosis, and this is in turn linked to the development of supraventricular tachycardias, especially atrial fibrillation. Sutton and Kenny pooled data from several studies (853 patients) and showed a 1-6% incidence of systemic emboli in AAI paced patients compared with 13% in VVI paced patients (p < 0001). 23 
For single chamber pacing, the AAI mode may be used. Ifthere is significant chronotropic incompetence, a rate responsive system (AAIR) can be chosen,25 although this imposes increased stress on atrioventricular conduction. Although many sensors are suitable for AAIR pacing, the QT interval is an obvious exception; atrial temperature based sensor systems can be unreliable, and even with activity based systems there have been problems.
AAI or AAIR pacing is inappropriate for patients with sinoatrial disease together with impaired atrioventricular conduction at the time of diagnosis. In addition, some of the patients with normal conduction at the time of implant may develop impairment of atrioventricular conduction with time. Rosenqvist et al documented the development of high grade atrioventricular block in 4 of 89 patients (4-5 %) paced from the atrium over a 4 year period. '9 Rosenqvist and Obel surveyed published reports and found 28 studies, relating to 1878 patients followed for a median period of three years.26 The median prevalence ofdevelopment of significant atrioventricular block was 2-1%, an annual incidence of 0-6%. Thus there is a risk of developing significant atrioventricular block with time, but the risk is low.
The development ofchronic atrial fibrillation will render atrial pacemakers ineffective, but many patients will have adequate ventricular response rates. Some suggest that dual chamber pacing should be the rule in patients with sinoatrial disorders because of these limitations,2 but this remains controversial.
If dual chamber pacing is chosen in patients with sinoatrial disease, care must be taken to select the correct mode. The high incidence of retrograde conduction in these patients means that there is often an ideal substrate for pacemaker mediated "endless loop" tachycardias. These may complicate DDD pacing so that DDI pacing is often preferred. The advent of dual chamber, sensor responsive pacemakers has allowed DDDR or DDIR pacing in these patients, with DDIR being ideal for many.
ATRIOVENTRICULAR BLOCK
The prognosis of patients with atrioventricular block is radically improved by even the simplest form of ventricular pacing.27 In certain cases this can be further improved by more sophisticated pacing, but in almost all cases the quality of life can be enhanced by the correct choice of pacemaker.2"
The principal determinant of cardiac output in paced patients is the heart rate.3' Patients with rate responsive pacemakers perform better during exercise than those with simple VVI devices, whether or not the increase in rate is achieved synchronously (VAT, VDD, or DDD pacemakers)' 3 32 or asynchronously (VVIR pacemakers).33 Pacemakers that provide only atrioventricular synchrony without atrial tracking (DVI or DDI modes) provide only a small increase in exercise performance.
As comparable improvement is obtained with VVIR and dual chamber pacing, what governs the choice between them? Single chamber VVIR pacing is simple to implement and is the method of choice when chronic atrial arrhythmias are present, when an atrial lead would be ineffective. Dual chamber systems avoid the pacemaker syndrome, which is common in VVI or VVIR modes, and if sinus node function is normal, use the best possible sensor-atrial rate. However, "endless loop" tachycardias are a very occasional nuisance. Initial programming is also simpler with DDD systems, because VVIR pacemakers require the correct relation between the sensor and exercise performance to be ascertained. Overall, the prognosis of patients with atrioventricular block has not been shown to be significantly improved by chosing dual chamber rather than ventricular pacing.35 However, Alpert et al found improved one, three and five year survival in a subset of patients with congestive heart failure treated with DDD compared with VVI pacing.35 Kenny et al also found particular benefit could be gained from treating patients with angina with dual chamber devices rather than ventricular systems, provided the upper rate was limited to 110 beats per minute.36 Rate responsive dual chamber pacemakers offer complete flexibility for patients with atrioventricular block who have additional chronotropic incompetence.
CAROTID SINUS SYNDROME
In these patients, sinus bradycardia or arrest is common, as is atrioventricular block. These aspects can easily be treated with pacing. The vasodepressor element is present to a greater or lesser degree in most patients, and may be exacerbated by ventricular pacing.37 Intact retrograde conduction is common (80%),37 and therefore the pacemaker syndrome is likely with ventricular pacing. Hysteresis (a feature where the pacemaker has a faster pacing rate than sensing rate) may reduce but not abolish these problems. Dual chamber pacing is preferred for these patients. Because the atrial rate response to exercise is usually normal and retrograde conduction is common, the DDI mode is usually recommended. broken, but if the rules are broken for purely budgetary reasons, this should be acknowledged as being the case. Only by doing this will optimal pacing facilities develop, arnd those in training may then understand clinical decisions to implant less than ideal pacemakers. Although a pacing service has to be provided within a limited budget, any saving made by choosing a cheaper pacing mode has to be set against limitations in the patient's quality and, in some cases, quantity of life. We, and many of our colleagues, do not always keep to our guidelines, but this is purely for fiscal reasonsit is important that we do not try to convince ourselves otherwise. When pacing practice is subjected to medical audit, the clinical outcome may be shown to outweigh any financial arguments.
